Butterfly Medical
Develops a minimally invasive implantable device to treat benign prostatic hyperplasia in men
$21MSeries C
Role not disclosedEI
European Innovation Council (EIC)
Activity from announced rounds
Activity in this selectionSeries C+
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $117.9M 2 disclosed · full round size, not this investor’s share